Clinical Trial Update: Efficacy of Omega-3 Fatty Acid Therapy in Preventing Gastrointestinal Bleeding in Patients With CF-LVAD [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating omega-3 fatty acid therapy to prevent GI bleeding in patients with continuous-flow left ventricular assist devices (CF-LVAD) was term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Bleeding
• Heart Failure

Drugs mentioned

• Omega-3 fatty acid therapy

Snippet

Sponsor: University of Chicago | Conditions: Heart Failure, Gastrointestinal Bleeding | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-07-13